In the absence of a submission from the holder of the marketing authorisation:
hydrocortisone (Plenadren®) is not recommended for use within NHS Scotland.
Indication under review: Treatment of adrenal insufficiency in adults.
The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland.
|Drug Name:||hydrocortisone (Plenadren)|
|SMC Drug ID:||848/12|
|Indication:||Treatment of adrenal insufficiency in adults.|
|Sub Category:||6.3 Corticosteroids|
|Submission Type:||Non submission|
|Date Advice Published:||14 January 2013|